|
Radiotherapy & Oncology
Journal of the European Society for Therapeutic Radiology and Oncology and affiliated to the Canadian Association of Radiation Oncology.
ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website: please go to  http://www.estro.org
and follow the links.
| |
ISSN: 0167-8140
Imprint: ELSEVIER
Radiotherapy and Oncology publishes papers describing original research as well as review articles.
It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental
work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to ... click here for full Aims & Scope
Radiotherapy and Oncology publishes papers describing original research as well as review articles.
It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, experimental
work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as physical aspects relevant to oncology, particularly in
the field of imaging, dosimetry and radiation therapy planning. Papers on more general aspects of interest to the radiation oncologist
including chemotherapy, surgery and immunology are also published. Papers are accepted on a worldwide basis. Manuscripts should be sent
to the following address:
Radiotherapy and Oncology Secretariat, Professor Jens Overgaard, M.D., Danish Cancer Society, Department
of Experimental and Clinical Oncology, Aarhus University Hospital, Building 5, Norrebrogade 44, DK 8000 Aarhus C, DENMARK (Tel: +45 89
49 26 29; Fax: +45 86 19 71 09; email: ro@oncology.dk).
A subscription to Radiotherapy and Oncology is included
in the membership fee of the European Society for Therapeutic Radiology and Oncology (ESTRO).
Further information can be obtained from the ESTRO Office, Av. E. Mounierlaan, 83/4, B-1200 Brussels, Belgium (Tel: +32 2 775 9340; Fax:
+32 2 779 5494; E-mail: info@estro.org).
Hide Aims & Scope
Editor-in-Chief:
J. Overgaard
|
|
